According to media reports citing individuals with knowledge of the matter, Eli Lilly is in negotiations to acquire psychedelic drug manufacturer Atai Beckley Inc (ATAI.O), with a potential deal announcement possibly arriving as early as this week.
Shares of Atai Beckley Inc surged 66% in after-hours trading, while shares of Eli Lilly remained flat. Data shows that Atai Beckley Inc has gained 31% year-to-date, with a market capitalization of $1.97 billion as of Wednesday's close.
The report indicates that Eli Lilly is negotiating to acquire the company at a premium.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments